James Investment Research Inc Organon & Co. Transaction History

James Investment Research Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$31.66 - $38.9 $506 - $622	-16 Reduced 94.12%	1 $0
Q1 2022 Apr 22, 2022	SELL	$30.45 - $39.36 $2,557 - $3,306	-84 Reduced 83.17%	17 $1,000
Q4 2021 Jan 28, 2022	SELL	$28.67 - $37.13 $716 - $928	-25 Reduced 19.84%	101 $3,000
Q3 2021 Oct 22, 2021	SELL	$28.63 - $35.64 $14,572 - $18,140	-509 Reduced 80.16%	126 $4,000
Q2 2021 Jul 26, 2021	BUY	$28.45 - $38.0 $18,065 - $24,130	635 New	635 $19,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

Stay updated on James Investment Research Inc with notifications on news.